Preferred name | scopolamine |
Trivial Name | (-)-Scopolamine |
Short Description | benzeneacetic acid, a-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (aS)- |
Formula | C17 H21 N O4 |
CAS Number | 51-34-3 |
Deleted CAS Number | 14797-94-5 |
ECHA Number | 200-090-3 |
FDA UNII | DL48G20X8X |
Bio Activity Summary | External link |
NMR Predictor | External link |
Synonyms |
|
Google Scholar | Start search |
Google Books | Start search |
Google Patents | Start search |
Perfumer & Flavorists | Start search |
EU Patents | Start search |
PubMeb | Start search |
NCBI | Start search |
NIST Chemistry WebBook: | Search Inchi |
Pubchem (cid): | 2723877 |
Pubchem (sid): | 134972272 |
(IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
Videos: | The Periodic Table of Videos |
tgsc: | Atomic Weights use for this web site |
(IUPAC): | Periodic Table of the Elements |
CHEBI: | View |
CHEMBL: | View |
KEGG (GenomeNet): | C01851 |
HMDB (The Human Metabolome Database): | HMDB03573 |
FooDB: | FDB023199 |
MedlinePlusSupp: | View |
VCF-Online: | VCF Volatile Compounds in Food |
ChemSpider: | View |
Wikipedia: | View |
Formulations/Preparations: •ophthalmic: solution: 0.25% isopto hyoscine (with benzalkonium chloride; viscous) (alcon). •parenteral: injection: 0.4 mgml scopolamine hydrobromide injection (with parabens), (abraxis). scopolamine hydrobromide •oral: tablets, soluble: 0.4 mg scopace, (hope). scopolamine hydrobromide •topical: transdermal system: approximately 1 mg72 hours (1.5 mg2.5 sq cm) transderm scop, (novartis). |
Material listed in food chemical codex | No |
Molecular weight | 303.35818481445 |
Vapor Pressure | 7.18 mmHg @ 25 °C |
Flash Point TCC Value | 232.2 °C TCC |
logP (o/w) | 0.98 |
Solubility | |
water, 1.00E+05 mg/L @ 25 °C (exp) | Yes |
water, 1.74e+004 mg/L @ 25 °C (est) | Yes |
Hazards identification | |
Classification of the substance or mixture | |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) | |
None found. | |
GHS Label elements, including precautionary statements | |
Pictogram | |
Hazard statement(s) | |
None found. | |
Precautionary statement(s) | |
None found. | |
Oral/Parenteral Toxicity: | |
intramuscular-human TDLo 4 ug/kg SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" "Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents," National Research Council, 3 vols., Washington, DC, National Academy Press, 1982-85Vol. 1, Pg. L1, 1982. intramuscular-man TDLo 24 ug/kg BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 32, Pg. 250, 1973. intraperitoneal-mouse LD50 400 mg/kg BEHAVIORAL: EXCITEMENT BEHAVIORAL: IRRITABILITY SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 1727, 1971. intravenous-mouse LD50 100 mg/kg Journal of Medicinal Chemistry. Vol. 26, Pg. 1772, 1983. oral-mouse LD50 1275 mg/kg BEHAVIORAL: REGIDITY BEHAVIORAL: TREMOR Archives Internationales de Pharmacodynamie et de Therapie. Vol. 134, Pg. 255, 1961. intravenous-rabbit LDLo 50 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. oral-rat LD50 2650 mg/kg Farm Chemicals Handbook. Vol. -, Pg. C272, 1991. | |
Dermal Toxicity: | |
subcutaneous-human TDLo 2 ug/kg BEHAVIORAL: EXCITEMENT BRAIN AND COVERINGS: CHANGES IN SURFACE EEG BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" Journal of Pharmacology and Experimental Therapeutics. Vol. 137, Pg. 133, 1962. subcutaneous-man TDLo 14 ug/kg BEHAVIORAL: ATAXIA BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" American Journal of Psychiatry. Vol. 141, Pg. 1010, 1984. subcutaneous-mouse LD50 1700 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 56, Pg. 85, 1936. subcutaneous-rabbit LDLo 75 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
Inhalation Toxicity: | |
Not determined |
Category: | |||
toxic natural substances | |||
Recommendation for scopolamine usage levels up to: | |||
not for fragrance use. | |||
Recommendation for scopolamine flavor usage levels up to: | |||
not for flavor use. |
European Food Safety Authority (EFSA) reference(s): |
Scientific Opinion on Tropane alkaloids in food and feed View page or View pdf |
Human acute exposure assessment to tropane alkaloids View page or View pdf |
EPI System: View |
ClinicalTrials.gov:search |
Daily Med:search |
AIDS Citations:Search |
Cancer Citations:Search |
Toxicology Citations:Search |
EPA GENetic TOXicology:Search |
EPA ACToR:Toxicology Data |
EPA Substance Registry Services (SRS):Registry |
Laboratory Chemical Safety Summary :2723877 |
National Institute of Allergy and Infectious Diseases:Data |
WGK Germany:3 |
Chemidplus:0000051343 |